Putting the STING into cancer immunotherapy
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
Four researchers with MIT ties earn 2023 Schmidt Science Fellowships
The illustrious prize supports early-career scientists and engineers as they pursue interdisciplinary work.
Chemists’ technique reveals whether antibodies neutralize SARS-CoV-2
The method could enable a rapid test to determine whether individuals are producing antibodies that help protect against Covid-19.
Vaccine printer could help vaccines reach more people
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
Championing health workers to lead vaccination efforts in Uganda
A survey to measure who was getting vaccinated against Covid-19 in Uganda finds health workers had an important role to play.
Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies
The global health care company Sanofi is providing $25 million to advance RNA research.
Creating a versatile vaccine to take on Covid-19 in its many guises
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
New purification method could make protein drugs cheaper
MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.
2022-23 Takeda Fellows: Leveraging AI to positively impact human health
New fellows are working on health records, robot control, pandemic preparedness, brain injuries, and more.
Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact
At an exhibition marking two decades since a transformative gift from the Picower Foundation, current and alumni members described research at the forefront of neuroscience and beyond.
SMART researchers develop quick test to determine immunity against Covid-19
Test that measures a person’s antibodies requires a drop of blood and takes just 10 minutes to show results.
Microparticles could be used to deliver “self-boosting” vaccines
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
Robert Langer wins BBVA Foundation Frontiers of Knowledge Award
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
3 Questions: Daniel Anderson on the progress of mRNA vaccines
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
A stark warning about threats to truth, science, and democracy
In annual Compton Lecture, celebrated journalist Martin Baron outlines how a growing disregard for facts undermines civil society in the U.S.